Texas SB2422 limits investigations and disciplinary actions by the Texas Medical Board regarding COVID-19 treatments and mask policies.

Texas SB2422 amends the Occupations Code to restrict the Texas Medical Board from investigating or taking punitive action against regulated individuals for prescribing or advocating ivermectin, hydroxychloroquine, or budesonide for COVID-19, making statements about mask efficacy, or failing to wear or require masks outside of pre-pandemic customary areas. The Board must expunge records from January 1, 2020, containing these terms, vacate any related disciplinary actions, refund fines, and reimburse legal fees.

Texas SB2422 limits investigations and disciplinary actions by the Texas Medical Board regarding COVID-19 treatments and mask policies.

Texas SB2422 amends the Occupations Code to restrict the Texas Medical Board from investigating or taking punitive action against regulated individuals for prescribing or advocating ivermectin, hydroxychloroquine, or budesonide for COVID-19, making statements about mask efficacy, or failing to wear or require masks outside of pre-pandemic customary areas. The Board must expunge records from January 1, 2020, containing these terms, vacate any related disciplinary actions, refund fines, and reimburse legal fees.